To goal of this clinical trial is to quantify the dose-response effects of aerobic exercise training compared to attention control on chemotherapy relative dose intensity in colon cancer survivors.
Age ≥18 years
Histologically confirmed stage II or III colon cancer
Completed surgical resection with curative intent
Plan to initiate chemotherapy
Evidence of metastatic colon cancer
Concurrently actively treated other (non-colon) cancer
Currently pregnant, breastfeeding, or planning to become pregnant within the next 24 weeks
Currently participating in another study with competing outcomes
AdventHealth Translational Research Institute
Lead sponsor
National Cancer Institute (NCI)
Collaborator